Landmark data from DREAM – the largest-ever diabetes prevention trial – was presented at the 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen-Malmö, Denmark-Sweden on September 15, 2006 and published in The Lancet (rosiglitazone) and the New England Journal of Medicine (ramipril). You can view an archive of the plenary presentation webcast on: www.dream-results.tv
DREAM Media Q&A Webcast
Immediately after the DREAM Plenary Presentation there was an interactive on-line media Q&A webcast for journalists. Please click here to view the post-plenary session webcast archive.
Related Materials:
|
